The Indian Vaccine Manufacturers Association (IVMA) has appointed Krishna Ella as the new President of the organization. The announcement was made on Monday, April 29th. Krishna Ella is the Co-Founder and Executive of Bharat Biotech, a prominent biotechnology company in India. As the new President, Ella will assume responsibility for leading and representing the IVMA, an important industry association in the country. This development holds significance for the Indian vaccine manufacturing sector and the biotechnology industry as a whole.

Ella’s appointment to IVMA presidency

Krishna Ella, the Co-Founder and Executive of Bharat Biotech, has been appointed as the President of the Indian Vaccine Manufacturers Association (IVMA). This announcement was made on Monday, April 29th, in Hyderabad, India. The IVMA is a significant industry association that plays a crucial role in the country’s vaccine manufacturing sector. As the new President, Ella will bring his expertise and experience to lead and represent the IVMA, effectively contributing to the growth and development of the Indian biotechnology industry.

Summary:

• Krishna Ella, Co-Founder and Executive of Bharat Biotech, has been appointed as the President of the Indian Vaccine Manufacturers Association (IVMA).
• The announcement of Ella’s appointment was made on Monday, April 29th.
• IVMA is a key industry association in India’s vaccine manufacturing sector.
• Ella’s appointment holds significance for the Indian biotechnology industry.

“I am honored to take up this responsibility and look forward to working closely with other members of the IVMA to further strengthen the vaccine manufacturing industry in India.” – Krishna Ella, President of IVMA.